Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis

Chimerism

Volumn 2, Issue 1, 2011, Pages 6-10

  Bloch, Evan M ^a   Reed, William F ^a,b   Lee, Tzong Hae ^a   Montalvo, Leilani ^a   Shiboski, Stephen ^c   Custer, Brian ^a   Barcellos, Lisa F ^d  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b CERUS CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Fetal cells; Microchimerism; Multiple sclerosis; Pregnancy; Twinning

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FETUS CELL; GENE SEQUENCE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROCHIMERISM; MULTIPLE SCLEROSIS; PREGNANCY; SELF REPORT; SIBLING; UMBILICAL CORD BLOOD; Y CHROMOSOME;

EID: 79953272843     PISSN: 19381956     EISSN: 19381964     Source Type: Journal    
DOI: 10.4161/chim.15151     Document Type: Article

References (34)

1. Steinman L, Martin R, Bernard C, Conlon P, Oksenberg JR. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu Rev Neurosci 2002; 25:491-505.
2. Murray TJ. The history of multiple sclerosis: the changing frame of the disease over the centuries. J Neurol Sci 2009; 277:3-8.
3. Chaudhuri A, Behan PO. Multiple sclerosis is not an autoimmune disease. Arch Neurol 2004; 61:1610-1612.
4. Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol 2004; 61:1613-1615.
5. Racke MK, Lovett-Racke AE, Karandikar NJ. The mechanism of action of glatiramer acetate treatment in multiple sclerosis. Neurology 2010; 74:25-30.
6. Willer CJ, Sadovnick AD, Ebers GC. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 2002; 126:126-133.
7. Bianchi DW. Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol 2000; 92:103-108.
8. Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, et al. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma 2004; 57:702-107.
9. Utter GH, Reed WF, Lee TH, Busch MP. Transfusion associated microchimerism. Vox Sang 2007; 93:188-195.
10. Nelson JL. Microchimerism in human health and disease. Autoimmunity 2003; 36:5-9.
11. Bianchi DW. Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 2000; 91:22-28.
12. Cirello V, Recalcati MP, Muzza M, Rossi S, Perrino M, Vicentini L, et al. Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res 2008; 68:8482-8488.
13. Willer CJ, Herrera BM, Morrison KM, Sadovnick AD, Ebers GC. Association between microchimerism and multiple sclerosis in Canadian twins. J Neuroimmunol 2006; 179:145-151.
14. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351:559-562.
15. Yan Z, Lambert NC, Guthrie KA, Porter AJ, Loubiere LS, Madeleine MM, et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005; 118:899-906.
16. Lambert NC, Pang JM, Yan Z, Erickson TD, Stevens AM, Furst DE, Nelson JL. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005; 64:845-848.
17. Reed W, Lee TH, Norris PJ, Utter GH, Busch MP. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin Hematol 2007; 44:24-31.
18. Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, et al. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 2005; 45:1280-1290.
19. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP. Survival of donor leukocyte subpopulations in immuno competent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999; 93:3127-3139.
20. Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss and time to clinical pregnancy: a population-based prospective study. Fertil Steril 2003; 79:577-584.
21. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 2003; 48:3237-3241.
22. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339:237-238.
23. Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP. Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction. Transfusion 1998; 38:1041-1045.
24. Montalvo L, Walker P, Wen L, Lim W, Reed W, Busch MP, Lee TH. Clinical investigation of posttransfusion Kidd blood group typing using a rapid normalized quantitative polymerase chain reaction. Transfusion 2004; 44:694-702.
25. Lee TH, Chafets D, Reed W, Wen L, Yang Y, Chen J, et al. Enhanced ascertainment of microchimerism with real-time quantitative PCR amplification of insertion/ deletion polymorphisms. Transfusion 2006; 46:1870-1878.
26. Nelson JL. Naturally acquired microchimerism: for better or for worse. Arthritis Rheum 2009; 60:5-7.
27. Guettier C, Sebagh M, Buard J, Feneux D, Ortin-Serrano M, Gigou M, et al. Male cell microchimerism in normal and diseased female livers from fetal life to adulthood. Hepatology 2005; 42:35-43.
28. Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 115:3-9.
29. Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 2005; 65:802-806.
30. Weber-Schoendorfer C, Schaefer C. Multiple sclerosis, immunomodulators and pregnancy outcome: a prospective observational study. Mult Scler 2009; 15:1037-1042.
31. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004; 74:160-167.
32. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003; 72:710-716.
33. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001; 41:1524-1530.
34. Lee TH, Wen L, Chrebtow V, Higuchi R, Watson RM, Sninsky JJ, Busch MP. Quantitation of residual WBCs in filtered blood components by high-throughput, realtime kinetic PCR. Transfusion 2002; 42:87-93.